RFA
ARKG icon

Register Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Register Financial Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-95
Closed -$2.23K – 324
2024
Q2 		$2.23K Hold
95
– – ﹤0.01% 656
2024
Q1 		$2.73K Buy
+95
New +$2.86K ﹤0.01% 658
2023
Q4 		– Sell
-95
Closed -$2.65K – 319
2023
Q3 		$2.65K Hold
95
– – ﹤0.01% 500
2023
Q2 		$3.24K Hold
95
– – ﹤0.01% 476
2023
Q1 		$2.86K Hold
95
– – ﹤0.01% 475
2022
Q4 		$2.68K Buy
+95
New +$3.02K ﹤0.01% 725

Other funds holding ARKG

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Register Financial Advisors's ARKG Position: Q3 2024 in Review

Register Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 95 shares — an estimated $2.23K sold.

Register Financial Advisors first reported a position in ARKG in Q4 2022 and held it in 6 quarters. The position peaked at $3.24K in Q2 2023. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • Register Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
  • Register Financial Advisors sold 95 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $2.23K.
  • Register Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 6 quarters.
  • Register Financial Advisors's ARK Genomic Revolution ETF position peaked at $3.24K in Q2 2023.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Register Financial Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.